Advances in targeted therapies XI.
Breedveld
F C
FC
LUMC, PO Box Leiden, Leiden 2300 RC, The Netherlands. f.c.breedveld@lumc.nl
Kalden
J R
JR
Smolen
J S
JS
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha